Clinical Trials Sponsored by Vicore Pharma AB

Total 201 results

Vicore Pharma AB

Completed

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension | Tolerance | Safety Issues

Sweden
Vicore Pharma AB

Completed

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

Endothelial Dysfunction | Type2diabetes

Sweden
Vicore Pharma AB

Completed

Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 (ATTRACT-2)

Covid19

India
Vicore Pharma AB

Completed

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects (ATTRACT-3)

COVID-19

Philippines, United States, Brazil, India, Russian Federation, Colombia, Argentina, Czechia, South Africa, Ukraine
Vicore Pharma AB

Completed

A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers

Drug Interaction

Sweden
Vicore Pharma AB
Orphan Reach

Completed

Safety and Efficacy of C21 in Subjects With COVID-19

COVID-19

India, United Kingdom
Vicore Pharma AB
Orphan Reach

Completed

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Idiopathic Pulmonary Fibrosis

United Kingdom, India, Ukraine, Russian Federation
Vicore Pharma AB
Curebase Inc.

Active, not recruiting

Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF (COMPANION)

Generalized Anxiety Disorder | Pulmonary Fibrosis

United States
Vicore Pharma AB
CTC Clinical Trial Consultants AB

Completed

Effect of C21 on Forearm Blood Flow

Study Vasodilatory Effects of C21

Sweden
Vicore Pharma AB
SGS Life Sciences, a division of SGS Belgium NV

Completed

Cold Challenge With C21 in RP

Systemic Sclerosis | Raynaud Phenomenon

United Kingdom
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
Vifor Pharma, Inc.

Recruiting

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

Hyperkalemia

United States, Israel
Vifor Pharma, Inc.

Terminated

FDDA Utilization Study (FDDAU)

Fatigue

Switzerland
Circius Pharma AB

Recruiting

Performance and Safety of Otinova® Ear Spray

Otitis Externa

Sweden
Hamlet Pharma AB

Recruiting

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

Czechia
NextCell Pharma Ab

Completed

Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes

Type1 Diabetes Mellitus

Sweden
Moberg Pharma AB

Completed

A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

United States, Canada
RSPR Pharma AB

Completed

Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.

Abdominal Aortic Aneurisms

Denmark
RSPR Pharma AB

Completed

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Abdominal Aortic Aneurysm

Sweden, United Kingdom, Denmark
Moberg Pharma AB

Completed

Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis

Onychomycosis

Sweden
Moberg Pharma AB

Completed

Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

Seborrhoeic Dermatitis of the Scalp

Sweden
Moberg Pharma AB

Completed

Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design (RIPT)

Erythema

United States
Ascelia Pharma AB

Completed

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function (SPARKLE)

Severe Renal Impairment | Known or Suspected Focal Liver Lesions

United States, Italy, Germany, Poland, Russian Federation, Sweden, Turkey, Argentina, Colombia, Mexico
Moberg Pharma AB

Active, not recruiting

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Onychomycosis

United States, Canada
Xspray Pharma AB

Completed

Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects

Pharmacokinetics | Bioavailability

United Kingdom
Natumin Pharma AB

Completed

Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis

Tinea Pedis

Sweden
Moberg Pharma AB

Completed

A Study of the Systemic Absorption of MOB015B

Onychomycosis

United States
RSPR Pharma AB

Completed

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Asthma

Denmark, Poland, Bulgaria, United Kingdom
RSPR Pharma AB

Completed

RSPR-007 Mannitol Challenge Trial

Asthma

Denmark
RSPR Pharma AB

Completed

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

Healthy Volunteers
Moberg Pharma AB

Completed

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

Sweden
Moberg Pharma AB

Completed

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

Actinic Keratosis

Germany
RSPR Pharma AB

Completed

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Duchenne Muscular Dystrophy | Becker Muscular Dystrophy

Sweden
Moberg Pharma AB

Completed

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects (Limsafe)

Healthy

Germany
Moberg Pharma AB

Completed

Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study

Atopic Dermatitis

Germany
Melius Pharma AB

Not yet recruiting

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) (COSMIC-IPF)

Cough | Idiopathic Pulmonary Fibrosis

India
BioGaia Pharma AB

Recruiting

A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis

Ulcerative Colitis

Sweden
Lokon Pharma AB

Recruiting

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Pancreatic Cancer

United States
Moberg Pharma AB

Completed

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (CIPT)

Erythema

United States
Karo Pharma AB

Completed

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

Onychomycosis

Tunisia
Karo Pharma AB

Completed

Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.

Chickenpox

Poland
Karo Pharma AB

Completed

Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms

Vulvovaginal Candidiasis

Poland
NextCell Pharma Ab

Active, not recruiting

Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes

Type1diabetes

Sweden
Karo Pharma AB

Completed

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

Plantar Wart | Common Wart

Poland
Karo Pharma AB

Completed

Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Bacterial Vaginosis

Poland
Karo Pharma AB

Completed

Hemoclin Gel for the Treatment of Hemorrhoids

Hemorrhoids Grade I and II

Poland
Moberg Pharma AB

Completed

Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

Germany, United Kingdom, Poland
Moberg Pharma AB

Completed

A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis

Onychomycosis
Moberg Pharma AB

Completed

K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp

Seborrhoeic Eczema of the Scalp

Sweden
Vifor Pharma

Completed

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF)

Chronic Heart Failure | Iron Deficiency

Netherlands

3

Subscribe